A

Adagio Therapeutics

94 employees

Adagio Therapeutics develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2020

Funding rounds raised

Total raised

$336M

from 19 investors over 19 rounds

A

Adagio Therapeutics raised $336M on April 19, 2021

Investors: Omega Funds, Polaris Partners, Mithril Capital Management LLC, RA Capital Management, L.P., Premji Invest, GV, OrbiMed Advisors, Redmile Group and Foresite Capital

A

Adagio Therapeutics raised $80M on November 10, 2020

Investors: Omega Funds, GV, OrbiMed Advisors, Mithril Capital Management LLC and Polaris Partners

A

Adagio Therapeutics raised $50M on July 16, 2020

Investors: Adimab, LLC, OrbiMed Advisors, Polaris Partners, Mithril Capital Management LLC and GV

FAQ